Balili, Teddy A.
HRN: 21-98-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2026
CEFTRIAXONE 1G (VIAL)
04/15/2026
04/21/2026
IV
2gm
Od
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: